Korean Circ J.  2022 Aug;52(8):604-605. 10.4070/kcj.2022.0175.

A ‘Gender Paradox’ of Female as a Stroke Risk in Atrial Fibrillation: Do Women Live Longer Than Men?

• Jeong JH
• Choi JI

• KMID: 2532330
• DOI: http://doi.org/10.4070/kcj.2022.0175

Reference

1. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137:263–272. PMID: 19762550.

2. Cho SM, Lee H, Kim HC. Sex- and age-specific trends in cardiovascular health in Korea, 2007–2018. Korean Circ J. 2021; 51:922–935. PMID: 34719898.

3. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42:373–498. PMID: 32860505.

4. Apostolakis S, Sullivan RM, Olshansky B, Lip GY. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. Chest. 2013; 144:1555–1563. PMID: 23669885.

5. Yong CM, Tremmel JA, Lansberg MG, Fan J, Askari M, Turakhia MP. Sex differences in oral anticoagulation and outcomes of stroke and intracranial bleeding in newly diagnosed atrial fibrillation. J Am Heart Assoc. 2020; 9:e015689. PMID: 32394763.

6. Sullivan RM, Zhang J, Zamba G, Lip GY, Olshansky B. Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). Am J Cardiol. 2012; 110:1799–1802. PMID: 22995971.

7. Wang KL, Lip GY, Lin SJ, Chiang CE. Non-vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis. Stroke. 2015; 46:2555–2561. PMID: 26304863.

8. Kim M, Kim J, Kim JB, et al. Association of gender with clinical outcomes in a contemporary cohort of patients with atrial fibrillation receiving oral anticoagulants. Korean Circ J. 2022; 52:593–603.

9. Lee KN, Choi JI, Boo KY, et al. Effectiveness and safety of off-label dosing of non-vitamin K antagonist anticoagulant for atrial fibrillation in Asian patients. Sci Rep. 2020; 10:1801. PMID: 32019993.

10. Kim YG, Han KD, Kim DY, et al. Different influence of blood pressure on new-onset atrial fibrillation in pre- and postmenopausal women: a nationwide population-based study. Hypertension. 2021; 77:1500–1509. PMID: 33719508.